Announcements
- Microbot Medical Continues to Ramp Up Patient Enrollment in its Pivotal Human Clinical Trial
- Microbot Medical Enrolled the First Patient in its Pivotal Human Clinical Trial
- Microbot Medical Partners with Baptist Hospital of Miami to Participate in its Pivotal Human Clinical Trial
- Microbot Medical Partners with Brigham and Women's Hospital for Its Pivotal Human Clinical Trial
- Microbot Medical Announces Brigham and Women's Hospital as a Site for its Pivotal Human Clinical Trial
- Microbot Medical Announces Closing of $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- Microbot Medical Announces $2.35 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
- Microbot Medical Has Received FDA Approval to Proceed with its Pivotal Human Clinical Trial
- Microbot Medical Announces Positive Results from the First Phase of its Collaboration with Corewell Health™
- Microbot Medical Shares Status Following Recent Geopolitical Events
More ▼
Key statistics
As of last trade, Microbot Medical Inc (CY9D:FRA) traded at 0.9865, 24.64% above the 52 week low of 0.7915 set on Apr 26, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.9865 |
---|---|
High | 0.9865 |
Low | 0.9865 |
Bid | 1.01 |
Offer | 1.03 |
Previous close | 0.973 |
Average volume | 69.44 |
---|---|
Shares outstanding | 15.97m |
Free float | 15.72m |
P/E (TTM) | -- |
Market cap | 17.48m USD |
EPS (TTM) | -0.8926 USD |
Data delayed at least 15 minutes, as of Jul 16 2024 07:16 BST.
More ▼